Position
Fidelity in Cartesian Therapeutics, Inc.
Back to the book · All holders of RNAC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.57M$6.15 → $10.42
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.37M | $9.86M | — | — | — | 0.0% |
| Q1 2026 | 799.7K | $4.92M | $6.15 | −$847.7K | −$4.09M | 0.0% |
| Q2 2026 | 368.4K | $3.84M | $10.42 | $1.57M | −$2.65M | 0.0% |